Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1α infusion in humans
- 31 March 1994
- Vol. 6 (2) , 215-219
- https://doi.org/10.1016/1043-4666(94)90044-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Detection of Tumor Necrosis Factor Soluble Receptor p55 in Blood Samples from Healthy and Endotoxemic HumansThe Journal of Infectious Diseases, 1993
- Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silicaCytokine, 1993
- Production of interleukin-1-receptor antagonist during experimental endotoxaemiaThe Lancet, 1991
- Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding ProteinDNA and Cell Biology, 1990
- Shedding of tumor necrosis factor receptors by activated human neutrophils.The Journal of Experimental Medicine, 1990
- A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral ProteinsScience, 1990
- Molecular cloning and expression of a receptor for human tumor necrosis factorCell, 1990
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989
- A human inhibitor of tumor necrosis factor alpha.The Journal of Experimental Medicine, 1988